Replies to post #18172 on Ariad Pharmaceuticals Inc fka ARIA

[adreamer]

Biopharma M&A Streak Continues:
AstraZeneca Buys Ardea for $1.26B Cash
In the fourth billion-plus-dollar deal of 2012, the UK’s second largest pharmaceutical firm, AstraZeneca, has acquired Ardea Biosciences Inc. for $1.26 billion. The cash-cow target: Ardea’s lesinurad, which is currently in Phase III development as a potential treatment for the chronic management of hyperuricemia in patients with gout.

[Whosetosay]

How about this for an explanation...TC knows he would get $10mm to stay on from any takover buyer of Ariad. If he sold 1/2 his holdings at $3M, TC figures the buyout to be at 3x15 pps, or $45 pps.

HB has no such landing pad. He must make his money on his holdings. Then he'll sit on a few boards.

Bottom line...Ariad will be bought out for $45.